The transfusion audit (i.e. clinical audit) is a quality improvement process that seeks to improve patient care and outcomes, through the systematic review of the use of transfused blood components ...

A one-time CRISPR-based gene therapy developed by Vertex Pharmaceuticals and CRISPR Therapeutics now has an additional FDA approval as a treatment for the rare blood disease beta thalassemia. The ...

Agios Pharmaceuticals AGIO announced that the FDA has approved Aqvesme (mitapivat) for the treatment of adult patients with alpha- or beta-thalassemia. With this approval, Aqvesme becomes the only FDA ...

Blood donation and transfusion save lives. Unfortunately, there’s also a long history of misinformation and fear around donations. For example, there was a time when blood donation was segregated by ...